BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27659538)

  • 1. The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization.
    Finkernagel F; Reinartz S; Lieber S; Adhikary T; Wortmann A; Hoffmann N; Bieringer T; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
    Oncotarget; 2016 Nov; 7(46):75339-75352. PubMed ID: 27659538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients.
    Adhikary T; Wortmann A; Finkernagel F; Lieber S; Nist A; Stiewe T; Wagner U; Müller-Brüsselbach S; Reinartz S; Müller R
    BMC Genomics; 2017 Mar; 18(1):243. PubMed ID: 28327095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype.
    Ko SY; Ladanyi A; Lengyel E; Naora H
    Am J Pathol; 2014 Jan; 184(1):271-81. PubMed ID: 24332016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment profoundly modifies functional status of macrophages: peritoneal and tumor-associated macrophages are two very different subpopulations.
    Rodríguez D; Silvera R; Carrio R; Nadji M; Caso R; Rodríguez G; Iragavarapu-Charyulu V; Torroella-Kouri M
    Cell Immunol; 2013; 283(1-2):51-60. PubMed ID: 23850963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor macrophages are pivotal constructors of tumor collagenous matrix.
    Afik R; Zigmond E; Vugman M; Klepfish M; Shimshoni E; Pasmanik-Chor M; Shenoy A; Bassat E; Halpern Z; Geiger T; Sagi I; Varol C
    J Exp Med; 2016 Oct; 213(11):2315-2331. PubMed ID: 27697834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment.
    Schumann T; Adhikary T; Wortmann A; Finkernagel F; Lieber S; Schnitzer E; Legrand N; Schober Y; Nockher WA; Toth PM; Diederich WE; Nist A; Stiewe T; Wagner U; Reinartz S; Müller-Brüsselbach S; Müller R
    Oncotarget; 2015 May; 6(15):13416-33. PubMed ID: 25968567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.
    Cortés M; Sanchez-Moral L; de Barrios O; Fernández-Aceñero MJ; Martínez-Campanario MC; Esteve-Codina A; Darling DS; Győrffy B; Lawrence T; Dean DC; Postigo A
    EMBO J; 2017 Nov; 36(22):3336-3355. PubMed ID: 29038174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.
    Reinartz S; Schumann T; Finkernagel F; Wortmann A; Jansen JM; Meissner W; Krause M; Schwörer AM; Wagner U; Müller-Brüsselbach S; Müller R
    Int J Cancer; 2014 Jan; 134(1):32-42. PubMed ID: 23784932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages.
    Jiang C; Yuan F; Wang J; Wu L
    Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C.
    Steitz AM; Steffes A; Finkernagel F; Unger A; Sommerfeld L; Jansen JM; Wagner U; Graumann J; Müller R; Reinartz S
    Cell Death Dis; 2020 Apr; 11(4):249. PubMed ID: 32312959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle-packaged miR-181c-5p from epithelial ovarian cancer cells promotes M2 polarization of tumor-associated macrophages via the KAT2B/HOXA10 axis.
    Yang S; Zhao H; Xiao W; Shao L; Zhao C; Sun P
    J Gene Med; 2022 Oct; 24(10):e3446. PubMed ID: 36027869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis.
    Xia H; Li S; Li X; Wang W; Bian Y; Wei S; Grove S; Wang W; Vatan L; Liu JR; McLean K; Rattan R; Munkarah A; Guan JL; Kryczek I; Zou W
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32780724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
    El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
    Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen Density Modulates the Immunosuppressive Functions of Macrophages.
    Larsen AMH; Kuczek DE; Kalvisa A; Siersbæk MS; Thorseth ML; Johansen AZ; Carretta M; Grøntved L; Vang O; Madsen DH
    J Immunol; 2020 Sep; 205(5):1461-1472. PubMed ID: 32839214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
    Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
    Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer.
    Lecker LSM; Berlato C; Maniati E; Delaine-Smith R; Pearce OMT; Heath O; Nichols SJ; Trevisan C; Novak M; McDermott J; Brenton JD; Cutillas PR; Rajeeve V; Hennino A; Drapkin R; Loessner D; Balkwill FR
    Cancer Res; 2021 Nov; 81(22):5706-5719. PubMed ID: 34561272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
    Scott EM; Jacobus EJ; Lyons B; Frost S; Freedman JD; Dyer A; Khalique H; Taverner WK; Carr A; Champion BR; Fisher KD; Seymour LW; Duffy MR
    J Immunother Cancer; 2019 Nov; 7(1):320. PubMed ID: 31753017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.